Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study.

Area of Science:

• Cell Biology
• Biochemistry
• Cancer Research

Background:

• Metabolic reprogramming is crucial for cancer cell survival and proliferation.
• Cancer cells alter nutrient uptake and metabolism to support rapid growth and macromolecule synthesis.

Purpose of the Study:

• To characterize proteome and metabolic changes in cancerous transformed mouse astrocytes using a quantitative proteomic approach.
• To investigate the enzymatic and metabolic reprogramming associated with in vitro astrocyte transformation.

Main Methods:

• Two-dimensional differential in-gel electrophoresis (2D-DIGE) for quantitative proteomic analysis.
• Enzymatic activity measurements and zymography to confirm changes in enzyme abundance and activity.
• Analysis of protein expression and metabolite abundance related to metabolic pathways.

Main Results:

• Transformed astrocytes exhibited increased expression of glycolytic enzymes, indicating enhanced aerobic glycolysis (Warburg effect).
• Cells showed increased capacity for lactate production to dispose of reducing equivalents.
• Reduced enzymatic capacity for tricarboxylic acid oxidation, glutamate metabolism, and oxidative stress defense was observed, along with decreased astroglial markers.

Conclusions:

• 2D-DIGE provides a comprehensive view of metabolic reprogramming in transformed astrocytes.
• Astrocyte transformation leads to loss of specific functions and metabolic adaptations favoring biosynthesis for tumor growth.
• This proteomic approach is applicable for studying transformed cell phenotypes and evaluating therapeutic interventions.